Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Obstetrics and Gynecology Reports
Published in: Current Obstetrics and Gynecology Reports 2/2016

01-06-2016 | Pelvic Organ Prolapse (M Weinstein, Section Editor)

Epidemiology of Pelvic Organ Prolapse

Authors: Maggie F. Wilkins, Jennifer M. Wu

Published in: Current Obstetrics and Gynecology Reports | Issue 2/2016

Login to get access

Abstract

Understanding and applying the epidemiology of pelvic organ prolapse (POP) is necessary to provide quality patient care to a growing and aging female population. As the elderly population is expected to almost double from 2012 to 2050, POP will become more prevalent, placing greater demands on our health care system and specialty-trained providers. In this review, we will evaluate and summarize recent literature and also highlight older studies of clinical significance that contribute to an overall understanding of the topic. While prevalence rates vary, the proportion of women with bothersome POP symptoms is approximately 3–6 % of women. POP is associated with decreased quality of life and a variety of bowel, bladder, and sexual dysfunction symptoms. Treatment options include expectant management, nonsurgical options, and surgery. For this review, we will review the prevalence of POP, trends in the management of POP, and future care needs with regard to POP.
Literature
1.
Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300(11):1311–6.CrossRefPubMedPubMedCentral
2.••
Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, et al. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol. 2014a;123(1):141–8. More recent than Nygaard et al. and with data from 2005 to 2010, this study used NHANES data to assess national POP prevalence trends over time and identify factors associated with these disorders to better target prevention efforts. CrossRefPubMedPubMedCentral
3.
Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J. 2013;24(11):1783–90.CrossRefPubMed
4.
Hall AF, Theofrastous JP, Cundiff GW, Harris RL, Hamilton LF, Swift SE, et al. Interobserver and intraobserver reliability of the proposed International Continence Society, Society of Gynecologic Surgeons, and American Urogynecologic Society pelvic organ prolapse classification system. Am J Obstet Gynecol. 1996;175(6):1467–70. discussion 70–1.CrossRefPubMed
5.
Swift S, Woodman P, O’Boyle A, Kahn M, Valley M, Bland D, et al. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol. 2005;192(3):795–806.CrossRefPubMed
6.
Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the Women’s Health Initiative: gravity and gravidity. Am J Obstet Gynecol. 2002;186(6):1160–6.CrossRefPubMed
7.
Cooper J, Annappa M, Dracocardos D, Cooper W, Muller S, Mallen C. Prevalence of genital prolapse symptoms in primary care: a cross-sectional survey. Int Urogynecol J. 2015;26(4):505–10.CrossRefPubMed
8.
Ellerkmann RM, Cundiff GW, Melick CF, Nihira MA, Leffler K, Bent AE. Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol. 2001;185(6):1332–7. discussion 7–8.CrossRefPubMed
9.
Doaee M, Moradi-Lakeh M, Nourmohammadi A, Razavi-Ratki SK, Nojomi M. Management of pelvic organ prolapse and quality of life: a systematic review and meta-analysis. Int Urogynecol J. 2014;25(2):153–63.CrossRefPubMed
10.
Swift SE, Tate SB, Nicholas J. Correlation of symptoms with degree of pelvic organ support in a general population of women: what is pelvic organ prolapse? Am J Obstet Gynecol. 2003;189(2):372–7. discussion 7–9.CrossRefPubMed
11.
Gutman RE, Ford DE, Quiroz LH, Shippey SH, Handa VL. Is there a pelvic organ prolapse threshold that predicts pelvic floor symptoms? Am J Obstet Gynecol. 2008;199(6):683 e1–7.CrossRefPubMed
12.
Bradley CS, Zimmerman MB, Qi Y, Nygaard IE. Natural history of pelvic organ prolapse in postmenopausal women. Obstet Gynecol. 2007;109(4):848–54.CrossRefPubMed
13.•
Gilchrist AS, Campbell W, Steele H, Brazell H, Foote J, Swift S. Outcomes of observation as therapy for pelvic organ prolapse: a study in the natural history of pelvic organ prolapse. Neurourol Urodyn. 2013;32(4):383–6. This study assessed progression and regression rates in women with symptomatic POP who elected for expectant management. Traditionally, data has been very limited regarding the natural history of POP; this study is important because it demonstrates that POP is not a universally progressive disease and therefore may help patients and providers to make better decisions about when to pursue treatment. CrossRefPubMed
14.
Gyhagen M, Akervall S, Milsom I. Clustering of pelvic floor disorders 20 years after one vaginal or one cesarean birth. Int Urogynecol J. 2015;26(8):1115–21.CrossRefPubMed
15.
Bai SW, Jeon MJ, Kim JY, Chung KA, Kim SK, Park KH. Relationship between stress urinary incontinence and pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(4):256–60. discussion 60.CrossRefPubMed
16.
Hagen S, Stark D. Conservative prevention and management of pelvic organ prolapse in women. Cochrane Database Syst Rev. 2011;12, CD003882.PubMed
17.
Wiegersma M, Panman CM, Kollen BJ, Berger MY, Lisman-Van Leeuwen Y, Dekker JH. Effect of pelvic floor muscle training compared with watchful waiting in older women with symptomatic mild pelvic organ prolapse: randomised controlled trial in primary care. BMJ. 2014a;349:g7378.CrossRefPubMedPubMedCentral
18.
Alperin M, Khan A, Dubina E, Tarnay C, Wu N, Pashos CL, et al. Patterns of pessary care and outcomes for Medicare beneficiaries with pelvic organ prolapse. Female Pelvic Med Reconstr Surg. 2013;19(3):142–7.CrossRefPubMedPubMedCentral
19.
Wiegersma M, Panman CM, Kollen BJ, Vermeulen KM, Schram AJ, Messelink EJ, et al. Pelvic floor muscle training versus watchful waiting or pessary treatment for pelvic organ prolapse (POPPS): design and participant baseline characteristics of two parallel pragmatic randomized controlled trials in primary care. Maturitas. 2014b;77(2):168–73.CrossRefPubMed
20.
Bump RC, Norton PA. Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am. 1998;25(4):723–46.CrossRefPubMed
21.•
Wu JM, Matthews CA, Conover MM, Pate V, Jonsson FM. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol. 2014b;123(6):1201–6. This population-based study estimated that the lifetime risk of undergoing surgery for POP is 12.6%, which represents current surgical practice among women with employer-based insurance from across the USA. CrossRefPubMedPubMedCentral
22.
Smith FJ, Holman CD, Moorin RE, Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol. 2010;116(5):1096–100.CrossRefPubMed
23.
Lowenstein E, Ottesen B, Gimbel H. Incidence and lifetime risk of pelvic organ prolapse surgery in Denmark from 1977 to 2009. Int Urogynecol J. 2015;26(1):49–55.CrossRefPubMed
24.••
Oversand SH, Staff AC, Spydslaug AE, Svenningsen R, Borstad E. Long-term follow-up after native tissue repair for pelvic organ prolapse. Int Urogynecol J. 2014;25(1):81–9. This study demonstrated very high satisfaction rates and low re-operation rates after native tissue repair for primary POP. This data is important because in an era when mesh augmentation is common and prior rates of re-operation have been reported as high as 29%, this supports native tissue repair as an appropriate first-line intervention for primary POP. CrossRefPubMed
25.
Risk of a subsequent surgery after an initial stress incontinence and/or pelvic organ prolapse procedure. American Urogynecologic Society, Seattle, WA, Oct 13–17, 2015. [Abstract] Female Pelvic Med Reconstr Surg. 2015 Sept/Oct. 21(5 Supp 2):S43.
26.
Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89(4):501–6.CrossRefPubMed
27.
Rogo-Gupta L, Rodriguez LV, Litwin MS, Herzog TJ, Neugut AI, Lu YS, et al. Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010. Obstet Gynecol. 2012;120(5):1105–15.PubMed
28.
Jonsson Funk M, Edenfield AL, Pate V, Visco AG, Weidner AC, Wu JM. Trends in use of surgical mesh for pelvic organ prolapse. Am J Obstet Gynecol. 2013;208(1):79 e1–7.CrossRefPubMed
29.
Skoczylas LC, Turner LC, Wang L, Winger DG, Shepherd JP. Changes in prolapse surgery trends relative to FDA notifications regarding vaginal mesh. Int Urogynecol J. 2014;25(4):471–7.CrossRefPubMedPubMedCentral
30.
Mascarenhas T, Mascarenhas-Saraiva Jr M, Ricon-Ferraz A, Nogueira P, Lopes F, Freitas A. Pelvic organ prolapse surgical management in Portugal and FDA safety communication have an impact on vaginal mesh. Int Urogynecol J. 2015;26(1):113–22.CrossRefPubMed
31.
32.
Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the prevalence of pelvic floor disorders in US Women: 2010 to 2050. Obstet Gynecol. 2009;114(6):1278–83.CrossRefPubMed
33.
Kirby AC, Luber KM, Menefee SA. An update on the current and future demand for care of pelvic floor disorders in the United States. Am J Obstet Gynecol. 2013;209(6):584 e1–5.CrossRef
34.
Yune JJ, Siddighi S. Perceptions and practice patterns of general gynecologists regarding urogynecology and pelvic reconstructive surgery. Female Pelvic Med Reconstr Surg. 2013;19(4):225–9.CrossRefPubMed
35.
Casiano ER, Wendel Jr GD, Congleton MJ, Wai CY. Urogynecology training and practice patterns after residency. J Surg Educ. 2012;69(1):77–83.CrossRefPubMed
Metadata
Title
Epidemiology of Pelvic Organ Prolapse
Authors
Maggie F. Wilkins
Jennifer M. Wu
Publication date
01-06-2016
Publisher
Springer US
Published in
Current Obstetrics and Gynecology Reports / Issue 2/2016
Electronic ISSN: 2161-3303
DOI
https://doi.org/10.1007/s13669-016-0149-z

Other articles of this Issue 2/2016

Current Obstetrics and Gynecology Reports 2/2016 Go to the issue

Pelvic Organ Prolapse (M Weinstein, Section Editor)

Native Tissue Surgery for Prolapse versus Graft/Mesh Use: Current Trends in Reconstructive Surgery

Pelvic Organ Prolapse (M Weinstein, Section Editor)

Uterine Conservation at the Time of Pelvic Organ Prolapse Treatment: the Options for Patients and Providers

Pelvic Organ Prolapse (M Weinstein, Section Editor)

Current Trends in Management of Defecatory Dysfunction, Posterior Compartment Prolapse, and Fecal Incontinence

Uterine Fibroids (N Narvekar, Section Editor)

The Role of Complementary and Alternative Medicine for the Management of Fibroids and Associated Symptomatology

Uterine Fibroids (N Narvekar, Section Editor)

An Overview of the Aetiology, Epidemiology, Symptomatology and Management of Uterine Fibroids

Uterine Fibroids (N Narvekar, Section Editor)

Fibroids and Infertility